Farms.com Home   News

Monitoring for Fungicide Resistance in the Soybean Sudden Death Syndrome Pathogen in Michigan

By Ryan Hamilton and Martin Chilvers 

Soybean sudden death syndrome symptoms on a soybean leaf

Soybean sudden death syndrome symptoms on a soybean leaf.

Michigan State University researchers are asking for your help to collect soybean sudden death syndrome (SDS) samples from across Michigan. Graduate student Ryan Hamilton is working on the Michigan Soybean Committee-supported project to monitor fungicide resistance in Fusarium virguliforme, the causal agent of sudden death syndrome.

Soybean sudden death syndrome is one of the most important yield-reducing diseases of soybeans in North America. The presence of sudden death syndrome was first confirmed in Michigan in 2010 and severe disease can result in yield losses greater than 50%.

The most noticeable symptoms of sudden death syndrome appear on leaves in the late vegetative through early reproductive growth stages, usually from late July through August, and may be worsened by heavy rains. Leaf symptoms begin as yellow spots between the leaf veins. As sudden death syndrome develops, these yellow spots turn brown, resulting in a mottled appearance while the leaf veins remain green. Shortly after, the leaves die and drop to the ground, while the petiole remains attached. Affected plants appear stripped, and pods and beans may be aborted.

A range of sudden death syndrome symptoms on soybean leaves

A range of sudden death syndrome symptoms on soybean leaves.

Foliar fungicide applications have no effect against F. virguliforme, but fungicidal seed treatments (ILEVO and Saltro) have been effective in preventing root infection and sudden death syndrome development later in the season. Because approved seed treatments for sudden death syndrome prevention share the same mode of action, monitoring for fungicide resistance is essential for effective long-term management.

Michigan State University Extension is conducting a study to detect fungicide resistance to the seed treatments currently in use. We are asking for your help to collect soybean sudden death syndrome samples from across Michigan. If you have seen sudden death syndrome symptoms in your fields and would like to contribute samples to assist in studying resistance to SDHI fungicides, please send samples to the Chilvers lab at MSU (address below). Information collected from these samples will help in the effective management of soybean sudden death syndrome in Michigan.

To send samples, collect about six whole plants that have shown sudden death syndrome symptoms and allow them to air-dry in a paper bag. Once the plants are dry, the fungus in the roots will be stable, and they can be shipped to:

Chilvers Lab
Attn: Ryan Hamilton – SDS Project
578 Wilson Rd, CIPS 107
East Lansing, MI 48824

Phone: 616-914-0238

Along with the samples, please include the following information:

  • Name and email address.
  • Nearest town and/or county.
  • History of SDS and/or soybean cyst nematodes in your fields.
  • Name of seed treatment used.
Source : msu.edu

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.